Published in Eur Heart J on March 01, 1989
Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Br J Pharmacol (1990) 0.83
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits. Br J Pharmacol (1992) 0.78
Platelets and cardiac arrhythmia. Front Physiol (2010) 0.76
Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods (1980) 3.10
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83
Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol (1973) 2.62
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res (1990) 2.51
The effect of hypercapnia on myocardial blood flow and metabolism. J Physiol (1970) 2.26
Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts. Br J Pharmacol (1972) 1.94
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation. Br J Pharmacol (1975) 1.91
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res (1992) 1.86
Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res (1974) 1.77
The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat. Br J Pharmacol (1974) 1.63
The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res (1993) 1.57
Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res (1968) 1.55
Myocardial vascular reactivity after beta-adrenergic blockade. Lancet (1966) 1.55
Haemodynamic and myocardial effects of hyperbaric oxygen in dogs subjected to haemorrhage. Cardiovasc Res (1971) 1.54
Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol (1982) 1.53
Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature (1981) 1.53
Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53
A species comparison of the effects of changing perfusion pressure on blood flow and metabolic heat production in the myocardium. J Physiol (1966) 1.46
Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure. Clin Exp Pharmacol Physiol (1975) 1.45
Studies on the mode of action of hexobendine, a prospective anti-anginal drug. Br J Pharmacol (1969) 1.39
The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation. Br J Pharmacol (1970) 1.31
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium. Br J Pharmacol (1973) 1.31
The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation. Br J Pharmacol (1969) 1.27
The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23
Pharmacological aspects of the coronary circulation. Prog Med Chem (1969) 1.23
The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol (1977) 1.23
Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol (1991) 1.21
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
The effects of amyl nitrite inhalation on myocardial blood flow and metabolic heat production. Br J Pharmacol Chemother (1967) 1.17
The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat. Br J Pharmacol (1976) 1.16
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemia. Br J Pharmacol (1981) 1.15
The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol (1980) 1.14
The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol (1981) 1.13
Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res (1991) 1.12
Adrenergic receptors in the coronary circulation. Am Heart J (1967) 1.12
Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity. Br J Pharmacol (1977) 1.12
Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. Br J Pharmacol (1981) 1.11
Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds. Br J Pharmacol (1980) 1.10
Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity. Cardiovasc Res (1989) 1.09
Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons. Cardiovasc Res (1969) 1.07
Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. Br J Pharmacol (1984) 1.05
The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium. Am Heart J (1973) 1.05
Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res (1998) 1.05
Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol (1983) 1.04
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol (1984) 1.04
The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Br J Pharmacol (1970) 1.04
Calcium antagonists prevent early post-infarction ventricular fibrillation. Eur J Pharmacol (1981) 1.04
Reduction in ventricular arrhythmias following acute coronary artery ligation in the dog after the administration of creatine phosphate. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.03
Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol (1994) 1.03
The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent. Br J Pharmacol (1977) 1.02
The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats. Br J Pharmacol (1983) 1.02
Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia. Br J Pharmacol (1986) 1.01
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol (1993) 1.01
The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs. Br J Pharmacol (1979) 1.00
Pharmacological approaches to the therapy of angina. Adv Drug Res (1974) 1.00
Haemodynamic and coronary effects of quazodine in cats with developing myocardial infarcts. J Pharm Pharmacol (1972) 0.99
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. Br J Pharmacol (1976) 0.99
Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds. Br J Pharmacol (1985) 0.98
The protective effect of sodium meclofenamate in experimental endotoxin shock. Br J Pharmacol (1975) 0.98
The effects of dipyridamole on coronary post-occlusion hyperaemia and on myocardial vasodilatation induced by systemic hypoxia. Br J Pharmacol (1972) 0.98
The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol (1983) 0.98
The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol (1989) 0.97
A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism. Br J Pharmacol Chemother (1966) 0.97
Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol (1983) 0.96
E. coli endotoxin shock in the cat; treatment with indomethacin. Br J Pharmacol (1975) 0.96
Dissociation between endothelium-mediated increases in tissue cGMP levels and modulation of aortic contractile responses. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.96
Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats. Br J Pharmacol (1969) 0.96
The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats. Br J Pharmacol (1984) 0.95
Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol (1990) 0.95
Nitroglycerin--the first one hundred years: new facts about an old drug. J Pharm Pharmacol (1979) 0.95
Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin. Br J Pharmacol (1981) 0.95
The early consequences of myocardial ischaemia and their modification. J Physiol (Paris) (1980) 0.94
The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine. Br J Pharmacol (1972) 0.94
The antidysrhythmic aminosteroid, ORG 6001, reduces the ST-segment elevation produced by coronary occlusion in the dog. Br J Pharmacol (1977) 0.92
Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med (2003) 0.91
The effects of histamine on the myocardial circulation. Eur J Pharmacol (1969) 0.91
Interventions for improving blood flow, oxygen availability and the balance between oxygen supply and demand in the acutely ischaemic myocardium. J Physiol (Paris) (1980) 0.91
The response of isolated cardiac muscle to acute anoxia: protective effect of adenosine triphosphate and creatine phosphate. J Pharm Pharmacol (1974) 0.91
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur J Pharmacol (1990) 0.91
Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning? Cardiovasc Res (1993) 0.91
An antiarrhythmic effect of adenosine during myocardial ischaemia and reperfusion. Eur J Pharmacol (1988) 0.91
The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol. Br J Pharmacol (1974) 0.91
The effects of dipyridamole on blood flow and oxygen handling in the acutely ischaemic and normal canine myocardium. Br J Pharmacol (1973) 0.90
Does the local myocardial release of prostaglandin E2 or F2alpha contribute to the early consequences of acute myocardial ischaemia? J Mol Cell Cardiol (1981) 0.90
Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide. J Mol Cell Cardiol (1999) 0.90
Cardiac electrophysiological effects of isoprenaline, phenylephrine, and noradrenaline on normal and mildly "ischaemic" sheep Purkinje fibers. J Cardiovasc Pharmacol (1989) 0.90
Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br J Pharmacol (1996) 0.90
Time course of the protection against ischaemia and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing. J Mol Cell Cardiol (1996) 0.89
Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol (1991) 0.89
The effect of adrenergic neurone blockade on the myocardial circulation. Br J Pharmacol Chemother (1967) 0.89
Effect of a coronary vasodilator drug (carbochromen) on blood flow and oxygen extraction in acute myocardial infarction. Cardiovasc Res (1973) 0.89
Delayed protection against ventricular arrhythmias by cardiac pacing. Heart (1997) 0.87
Antiarrhythmic actions of adenosine in the early stages of experimental myocardial ischaemia. Eur J Pharmacol (1984) 0.87
Exdotoxin-induced metabolic changes in the conscious, unrestrained rat: hypoglycemia and elevated blood lactate concentrations without hyperinsulinemia. Circ Shock (1981) 0.87
Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: effects of adrenal demedullation and/or guanethidine treatment. Circ Shock (1985) 0.87
Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors. J Cardiovasc Pharmacol (1985) 0.87
Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites. Circ Shock (1990) 0.87